Baxter International Inc - Net Worth and Insider Trading

Baxter International Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Baxter International Inc owns 5 companies in total, including Baxalta Inc (BXLT) , CTI BioPharma Corp (CTIC) , and Traws Pharma Inc (TRAW) among others .

Click here to see the complete history of Baxter International Inc’s form 4 insider trades.

Insider Ownership Summary of Baxter International Inc

Ticker	Comapny	Transaction Date	Type of Owner
BXLT	Baxalta Inc	2016-03-21	10 percent owner
CTIC	CTI BioPharma Corp	2013-11-15	10 percent owner
TRAW	Traws Pharma Inc	2013-07-24	10 percent owner
		2012-08-11	10 percent owner
		2021-06-23	10 percent owner

Baxter International Inc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Baxter International Inc Ownership Network

Ownership Network List of Baxter International Inc

No Data

Ownership Network Relation of Baxter International Inc

Baxter International Inc Owned Company Details

What does Baxalta Inc do?

Who are the key executives at Baxalta Inc?

Baxter International Inc is the 10 percent owner of Baxalta Inc. Other key executives at Baxalta Inc include EVP & Head of Human Resources Anne-marie Law , EVP and President & Hematology Brian Goff , and See Remarks John J Orloff .

Baxalta Inc (BXLT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Baxalta Inc (BXLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Baxalta Inc (BXLT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Baxalta Inc (BXLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Baxalta Inc Insider Transactions

No Available Data

What does CTI BioPharma Corp do?

Who are the key executives at CTI BioPharma Corp?

Baxter International Inc is the 10 percent owner of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .

CTI BioPharma Corp (CTIC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

CTI BioPharma Corp Insider Transactions

No Available Data

What does Traws Pharma Inc do?

Who are the key executives at Traws Pharma Inc?

Baxter International Inc is the 10 percent owner of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .

Traws Pharma Inc (TRAW) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.

Traws Pharma Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Baxter International Inc is the 10 percent owner of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, Baxter International Inc made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Miromatrix Medical Inc do?

Who are the key executives at Miromatrix Medical Inc?

Baxter International Inc is the 10 percent owner of Miromatrix Medical Inc. Other key executives at Miromatrix Medical Inc include Chief Financial Officer James Michael Douglas , Vice President of R&D John Joseph Barry , and Chief Executive Officer Jeffrey James Ross .

Miromatrix Medical Inc (MIRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Miromatrix Medical Inc (MIRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Miromatrix Medical Inc (MIRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Miromatrix Medical Inc (MIRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Miromatrix Medical Inc Insider Transactions

No Available Data

Baxter International Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Baxter International Inc. You might contact Baxter International Inc via mailing address: One Baxter Parkway, Df2-1w, Deerfield Il 60015.

Discussions on Baxter International Inc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.